Original paper
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
Paper Details
Title
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
Published Date
Jan 12, 2017
Journal
Volume
102
Issue
4
Pages
e132 - e135
Notes
History